Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corneal tissue consists of five main layers: the *epithelium* (regenerative protective surface), *Bowman's layer* (collagenous acellular barrier), *stroma* (collagen-rich connective tissue for transparency and strength), *Descemet's membrane* (basement membrane for endothelium), and *endothelium* (monolayer regulating hydration)[5][6]. The stroma comprises mainly type I and V collagen fibrils, organized to minimize light scattering, interspersed with keratocytes and small leucine-rich proteoglycans (lumican, decorin, keratocan, biglycan)[1][2][3][4]. Its primary biological role is maintaining vision by providing a transparent, strong, and smooth surface for light entry. As a tissue or organ, "corneal tissue" cannot be considered a precise molecular therapeutic target; rather, its individual molecular components (e.g., collagen, proteoglycans, ion channels) may serve as therapeutic, diagnostic, or research targets.
Not specific to a molecule; actions depend on drug class Antibiotics: inhibit bacterial growth at the corneal surface Corticosteroids: reduce inflammatory cytokine production Immunomodulators: suppress T-cell mediated inflammation
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal tissue.